Highlights Movano Inc.

Equities

MOVE

US62459M1071

End-of-day quote Nasdaq Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
0.435 ^USD	+10.15%		-7.45%	-44.33%

09/05	Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision	CI
17/04	Movano Inc. announced that it has received $24.128792 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision	09/05	CI
Movano Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05/04	CI
Movano to Raise $24 Million From Share Placement	03/04	MT
Movano Health's Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial	15/03	CI
Movano Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring	31/23/31	CI
Movano Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Movano Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
MOVANO INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	31/23/31	AQ
Movano Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	20/23/20	CI
Movano Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	20/23/20	CI
Movano Health Says It Secured 3 Patents Covering Methods for Radio Frequency-Enabled Glucose, Blood Pressure Monitoring	15/23/15	MT
Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women	28/22/28	CI
Movano Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Movano Inc. Announces Beta Program with Stanford University to Advance the Development of Comprehensive Health Data Monitoring for its Wearable Ring Solution	16/22/16	CI
Movano Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Movano Ring Exceeds Accuracy Targets for SpO2 and Heart Rate Monitoring in Initial Hypoxia Study; Company Eyes FDA Submission	09/22/09	CI
Movano Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Movano Inc. Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring	13/22/13	CI
Movano Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	31/22/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Movano Inc.

Equities

MOVE

US62459M1071

Highlights

Filters